Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Loading live signals…
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Acquiring Company
Eli Lilly and Company
Acquired Company
Kelonia Therapeutics
IndianapolisBostonBiotechnologyHealth CareMedicalDescription
Eli Lilly and Company has entered into a definitive agreement to acquire Kelonia Therapeutics for up to $7 billion. The deal includes an upfront payment of $3.25 billion with additional payments contingent on clinical and regulatory milestones. Kelonia's innovative gene placement technology aims to enhance CAR-T therapy accessibility.
Related People
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed